Markets open

Waters Corporation

WAT · NYSE

Analyst Consensus

Buy

17 analysts

$394

Current

—

Low

$420

Average

—

High

Average target implies +6.48% versus the current price.

The ratings synthesis for WAT has not been generated yet.

Rating Actions

No individual rating actions have been captured for WATyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

CITIGROUP

CO FORECST

DEUTSCHE BK SEC

EVERCORE ISI

JEFFERIES & CO.

JP MORGAN SECUR

KEYBANC CAP MKT

LEERINK PARTNRS

SANFORD BERNSTE

STIFEL NICOLAUS

TD COWEN

UBS

WOLFE RESEARCH

ZACKS RESEARCH

Symbol: WAT
Type: Stock
Sector: Industrials
Industry: Biotechnology: Laboratory Analytical Instruments
Country: North America
Exchange: NYSE

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.